|
May 12
|
High Growth Tech Stocks In Europe Featuring Three Promising Picks
|
|
May 10
|
Pharming Group First Quarter 2025 Earnings: US$0.022 loss per share (vs US$0.019 loss in 1Q 2024)
|
|
May 9
|
Pharming Group (PHGUF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth ...
|
|
May 8
|
Pharming Group reports first quarter 2025 financial results and provides business update
|
|
May 7
|
Earnings To Watch: Pharming Group (PHGUF) Reports Q1 2025 Result
|
|
Apr 30
|
Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director
|
|
Apr 25
|
Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
|
|
Apr 25
|
SpringWorks Therapeutics (SWTX) Soars 9.0%: Is Further Upside Left in the Stock?
|
|
Apr 24
|
Pharming announces positive recommendation from NICE for Joenja
|
|
Apr 24
|
Pharming Group to report first quarter 2025 financial results on May 8
|
|
Apr 23
|
Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS
|
|
Mar 14
|
Pharming Group (PHGUF) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|
|
Mar 14
|
3 European Penny Stocks With Market Caps Over €300M
|
|
Mar 14
|
Pharming Group Full Year 2024 Earnings: EPS Beats Expectations
|
|
Mar 13
|
Pharming Group reports fourth quarter and full year 2024 financial results and provides business update
|
|
Feb 20
|
Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent
|